LVAD recipients were much less likely to need an opioid prescription at discharge and much more likely to be free of chronic opioids 18 months later after Cleveland Clinic launched an opioid-sparing regimen.
New protocol is striking because it shows that an opioid-sparing approach can work for patients who’ve undergone a major open-heart procedure.
Preliminary results of our postop pain management study are exceptionally promising, suggesting no deep infections or nerve injuries in the catheter group.
Dedicated pain management team works 24/7 to preempt patients’ postop pain. As a result, patients need less opioids and have shorter hospital stays. Surgery-specific, evidence-based pathways make it possible.